Haleon and Tamro continue cooperation in Finland

- We are extremely pleased to continue our collaboration with Tamro by entering this new, multi-year contract. Tamro has a proven track record of delivering outstanding warehousing and distribution services and has been a reliable partner for many years. We look forward to our continued collaboration and the important role they play in supporting our purpose of delivering better everyday health with humanity says Carlos Oropeza, General Manager for Haleon.

- We’re delighted to extend our collaboration with our long-term partner. We are proud at Tamro to be able to ensure the availability throughout Finland of Haleon’s excellent and successful products, such as Panadol, Voltaren, Nicotinell, and Otrivin says Tamro’s Key Account Manager Petteri Lajolinna.

About Haleon

Haleon is a global leader in consumer health, with brands trusted by millions of consumers globally. The group employs over 22,000 people across 170 markets, who are united by Haleon’s purpose - to deliver better everyday health with humanity. Haleon’s product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

Learn more: www.haleon.com/

Tamro Corporation 

Tamro’s mission is to deliver health. We deliver almost 60 percent of all pharmaceuticals required in hospitals, pharmacies and retail stores throughout Finland. In addition to distributing pharmaceuticals and other health products, we offer data-driven services, sales and marketing services, as well as digital home care solutions. As part of the Finnish healthcare network, we have been involved in developing and improving both pharmaceutical services and the wellbeing of Finnish people since 1895. 

Tamro Corporation´s turnover is 1.6 billion euros, and we currently employ 470 professionals. Our subsidiaries and joint ventures include Medaffcon Oy and Pharmac Finland Oy. Tamro is part of PHOENIX group, the leading healthcare service provider in Europe.  

Learn more: www.tamro.fi/en